Study Title: Phase II Trial of Sparing the Urethra, Pudendal Artery and Rectum During Stereotactic Ablative Body Radiotherapy (SUPR-SABR) for Favorable and Intermediate Risk Prostate Cancer
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Eldredge-Hindy, Harriet, at eldredge@musc.edu.Study Coordinator, Bargeloh, Zachary, at bargeloh@musc.edu.Trial opened at the following institutions: Medical University of South Carolina